Baltimore, MD – According to filings with the U.S. Securities and Exchange Commission, CDI Laboratories is raising $5,000,000.00 in new funding. Sources indicate as part of senior management President and Chief Executive Officer, Ignacio Lopez-Castro played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About CDI Laboratories

CDI Laboratories is the NextGen Proteomics company, a result of intensive efforts and advances made by synthetic biologists at the Johns Hopkins University School of Medicine. The company was created by scientists for scientists to address critical needs required accelerate research, advance discoveries, and translate these discoveries into novel products and services that improve human health. Our flagship product, HuProt the Human Proteome Microarray has gone through several upgrades in content & print quality.

To learn more about CDI Laboratories, visit http://cdi.bio/

Contact:
Ignacio Lopez-Castro, President and Chief Executive Officer
844-539-6296
https://www.linkedin.com/in/ignaciopino/

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved